Response to ipilimumab therapy of patient case 2. (A) Radiographic progression of disease at week 12, followed by a clinical response and near complete resolution of disease following another course of ipilimumab induction therapy. (B) Lymphocyte recovery consistent with immune reconstitution accompanied by a decline in LDH and alkaline phosphatase, reflective of decreasing tumor burden.